日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failure

复发或难治性急性髓系白血病在menin抑制失败后的预后

Chin, Kuo-Kai; Ball, Brian J; Abaza, Yasmin; Altman, Jessica K; Thakur, Rahul K; Ali, Moiez; Derkach, Andriy; Geyer, Mark B; Goldberg, Aaron D; Haque, Tamanna Z; Thompson, Meghan C; Park, Jae H; Tallman, Martin S; Cai, Sheng F; Wang, Eunice S; Aldoss, Ibrahim T; Stein, Eytan M

Survival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trial

接受强化治疗或克拉屈滨治疗的急性髓系白血病老年患者的生存情况:E2906 III期试验

Foran, James M; Sun, Zhuoxin; Luger, Selina M; Claxton, David F; Lazarus, Hillard M; Arber, Daniel A; Rowe, Jacob M; Paietta, Elisabeth; Racevskis, Janis; Garrett-Bakelman, Fran; Zhang, Yanming; Altman, Jessica K; Al-Kali, Aref; Zheng, Hong; Pratz, Keith W; Broun, E Randolph; Powell, Bayard L; O'Dwyer, Kristen Marie; Godwin, John E; Ofran, Yishai; Litzow, Mark R; Tallman, Martin S

Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality: The ECOG-ACRIN EA9131 Trial

急性早幼粒细胞白血病和早期死亡率的学术界合作:ECOG-ACRIN EA9131试验

Jillella, Anand P; Lee, Sandra J; Altman, Jessica K; Luger, Selina M; Tallman, Martin S; Foran, James M; Bradshaw, Danielle; Law, Lisa Y; Bryan, Locke J; Abou Zahr, Abdallah; Begna, Kebede H; Perl, Alexander E; Vadakara, Joseph J L; Qamar, Rubina; Bergan, Raymond C; Fisch, Michael J; Carlos, Ruth C; Wagner, Lynne I; Kota, Vamsi K; Litzow, Mark R

Early death and intracranial hemorrhage prediction in acute promyelocytic leukemia: validation of a risk score in a cohort from an international consortium treated with chemotherapy plus all-trans retinoic acid

急性早幼粒细胞白血病早期死亡和颅内出血预测:一项来自国际联盟、接受化疗联合全反式维甲酸治疗队列的风险评分验证

Silva, Wellington F; Kim, Haesook T; Undurraga, Maria S; Navarro-Cabrera, Juan R; Salinas, Victor; Muxi, Pablo; Melo, Raul A M; Gloria, Ana Beatriz F; Pagnano, Katia B B; Nunes, Elenaide C; Bittencourt, Rosane Isabel; Rojas, Ninoska; Truyenque, Shirley M Q; Ayala-Lugo, Ana Ilda; Oliver, Ana Carolina; Figueiredo-Pontes, Lorena L; Traina, Fabiola; Moreira, Frederico; Fagundes, Evandro M; Duarte, Bruno K L; Mora-Alferez, Analí Pamela; Ortiz, Percy; Untama, Jose Luis; Tallman, Martin S; Ribeiro, Raul C; Ganser, Arnold; Dillon, Richard James; Valk, Peter J M; Sanz, Miguel A; Löwenberg, Bob; Berliner, Nancy; Rego, Eduardo M

Patients with high-risk acute promyelocytic leukemia need maintenance therapy for 1 year - the PROS

高危急性早幼粒细胞白血病患者需要接受为期1年的维持治疗——PROS

Tallman, Martin S

Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction

患有急性髓系白血病 (AML) 且携带 IDH2-R172 突变的患者对强化化疗诱导治疗表现出独特的初始反应。

Yisraeli Salman, Meira; Terry, Alexander R; Derkach, Andriy; Nemirovsky, David; Chin, Kuo-Kai; Valtis, Yannis K; Boussi, Leora; Spivey, Theresa; Xiao, Wenbin; Famulare, Christopher; Ciervo, Jenna; Rowe, Jacob M; Tallman, Martin S; Stein, Eytan M

Outpatient cytarabine consolidation in acute myeloid leukemia safely reduces hospitalization time and treatment costs

急性髓系白血病患者在门诊接受阿糖胞苷巩固治疗可安全有效地缩短住院时间和降低治疗成本。

Burton, Hannah; Boussi, Leora; Nemirovsky, David; Derkach, Andriy; Ciervo, Jenna; Famulare, Christopher; Chin, Kuo-Kai; Valtis, Yannis; Yisraeli Salman, Meira; Patel, Kishan; Shah, Gunjan L; Goldberg, Aaron D; Geyer, Mark B; Thompson, Meghan C; Tallman, Martin S; Stein, Eytan M; Cai, Sheng F

HMA/VEN treatment modifications and associated outcomes in IDH-mutant AML

IDH突变型急性髓系白血病中HMA/VEN治疗方案的调整及相关预后

Chin, Kuo-Kai; Derkach, Andriy; Famulare, Christopher; Gupta, Gaurav K; Borge, P Dayand; Geyer, Mark B; Goldberg, Aaron D; Haque, Tamanna; Park, Jae H; Roeker, Lindsey E; Tallman, Martin S; Stahl, Maximilian; Stein, Eytan M

Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults

Blinatumomab 用于治疗成人 MRD 阴性急性淋巴细胞白血病

Litzow, Mark R; Sun, Zhuoxin; Mattison, Ryan J; Paietta, Elisabeth M; Roberts, Kathryn G; Zhang, Yanming; Racevskis, Janis; Lazarus, Hillard M; Rowe, Jacob M; Arber, Daniel A; Wieduwilt, Matthew J; Liedtke, Michaela; Bergeron, Julie; Wood, Brent L; Zhao, Yaqi; Wu, Gang; Chang, Ti-Cheng; Zhang, Wenchao; Pratz, Keith W; Dinner, Shira N; Frey, Noelle; Gore, Steven D; Bhatnagar, Bhavana; Atallah, Ehab L; Uy, Geoffrey L; Jeyakumar, Deepa; Lin, Tara L; Willman, Cheryl L; DeAngelo, Daniel J; Patel, Shejal B; Elliott, Michelle A; Advani, Anjali S; Tzachanis, Dimitrios; Vachhani, Pankit; Bhave, Rupali R; Sharon, Elad; Little, Richard F; Erba, Harry P; Stone, Richard M; Luger, Selina M; Mullighan, Charles G; Tallman, Martin S

Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trial

与化疗免疫疗法相比,基于伊布替尼的疗法可重新激活 CD8+ T 细胞:来自 E1912 试验的免疫监测结果

Papazoglou, Despoina; Wang, Xin Victoria; Shanafelt, Tait D; Lesnick, Connie E; Ioannou, Nikolaos; De Rossi, Giulia; Herter, Sylvia; Bacac, Marina; Klein, Christian; Tallman, Martin S; Kay, Neil E; Ramsay, Alan G